PET Expert Panel Scans Alzheimer’s National Coverage Options
This article was originally published in The Gray Sheet
Executive Summary
CMS is considering limiting reimbursement of FDG PET for Alzheimer's disease diagnosis to specific clinical trial participants, according to Coverage & Analysis Group Director Steve Phurrough, MD